# Kiribati Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Kiribati HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Kiribati (KIR)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $73.5K
- Products: 21
- Buyer markets: 10
- Average CAGR: -10.7%
- Global sector size: $81.2B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $76.8B | $101.5 | $19.0B | -38.0% | 2 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $1.1B | $484.8 | $794.5M | +10.3% | 2 | +0.0% |
| HS 300590 - Wadding, gauze, bandages and similar articles: (excluding adhesive dressings), impregnated or coated with pharmaceutical substances, packaged for retail sale | $928.2M | $5.4K | $410.8M | -27.0% | 2 | +0.2% |
| HS 370790 - Photographic goods: chemical preparations other than sensitised emulsions, put up in measured portions or put up for retail sale in a form ready for use | $478.9M | $1.7K | $380.9M | -37.5% | 1 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $1.1B | $1.1K | $336.6M | +13.9% | 1 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $401.0M | $129.1 | $281.6M | +4.4% | 2 | +0.0% |
| HS 380991 - Finishing agents and dye carriers: to accelerate dyeing or fixing of dye-stuffs, other products and preparations, used in the textile industry (excluding those with a basis of amylaceous substances) | $240.2M | $5.4K | $174.8M | -9.7% | 1 | +0.0% |
| HS 300610 - Pharmaceutical goods: sterile surgical catgut, suture materials, tissue adhesives, laminaria, laminaria tents, absorbable surgical or dental haemostatics, and surgical or dental adhesion barriers | $101.3M | $449.7 | $75.0M | -26.2% | 1 | +0.0% |
| HS 330690 - Oral or dental hygiene preparations: other than dentifrices | $20.3M | $669.0 | $12.9M | -24.0% | 1 | +0.0% |
| HS 340211 - Organic surface-active agents: anionic (other than soap), whether or not put up for retail sale | $18.5M | $41.2K | $10.8M | +22.7% | 1 | +0.2% |
| HS 370110 - Photographic plates and film: for x-ray, in the flat, sensitised, unexposed, of any material other than paper, paperboard or textiles | $19.4M | $4.8K | $7.1M | -41.9% | 1 | +0.0% |
| HS 300670 - Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments | $11.1M | $46.1 | $4.6M | +6.3% | 1 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $3.0M | $518.9 | $2.0M | -6.0% | 1 | +0.0% |
| HS 350699 - Glues and other adhesives: prepared, n.e.s. in heading no. 3506, not exceeding a net weight of 1kg | $3.4M | $23.3 | $1.8M | -15.8% | 2 | +0.0% |
| HS 321410 - Mastics: painters' fillings | $2.1M | $106.0 | $1.3M | -14.9% | 1 | +0.0% |
| HS 300230 - Vaccines: for veterinary medicine | $863.0K | $4.5K | $1.2M | +84.1% | 1 | +7.9% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $1.6M | $35.9 | $1.1M | -28.2% | 1 | +0.0% |
| HS 300450 - Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | $1.1M | $609.1 | $917.9K | -31.5% | 1 | +0.3% |
| HS 300410 - Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | $1.2M | $1.4K | $667.9K | -27.8% | 1 | +0.2% |
| HS 320890 - Paints and varnishes: based on polymers n.e.s. in heading no. 3208, dispersed or dissolved in a non-aqueous medium | $1.2M | $4.7K | $518.8K | +9.1% | 1 | +0.6% |
| HS 300449 - Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale | $589.7K | $11.5 | $486.5K | -34.2% | 1 | +0.1% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $19.8B calculated opportunity across 4 products.
- Canada (CAN): $790.7M calculated opportunity across 1 products.
- United Arab Emirates (ARE): $336.6M calculated opportunity across 1 products.
- Republic of Korea (KOR): $278.7M calculated opportunity across 1 products.
- Germany (DEU): $174.8M calculated opportunity across 1 products.
- Australia (AUS): $79.6M calculated opportunity across 2 products.
- Fiji (FJI): $25.6M calculated opportunity across 13 products.
- Ireland (IRL): $12.9M calculated opportunity across 1 products.
- Pakistan (PAK): $10.8M calculated opportunity across 1 products.
- Vanuatu (VUT): $460.7K calculated opportunity across 1 products.

## Growth stars

- HS 300230: +84.1% average CAGR, $1.2M calculated opportunity.
- HS 340211: +22.7% average CAGR, $10.8M calculated opportunity.
- HS 330499: +13.9% average CAGR, $336.6M calculated opportunity.
- HS 382200: +10.3% average CAGR, $794.5M calculated opportunity.
- HS 320890: +9.1% average CAGR, $518.8K calculated opportunity.
- HS 300670: +6.3% average CAGR, $4.6M calculated opportunity.
- HS 300220: +4.4% average CAGR, $281.6M calculated opportunity.
- HS 300390: -6.0% average CAGR, $2.0M calculated opportunity.
- HS 380991: -9.7% average CAGR, $174.8M calculated opportunity.
- HS 321410: -14.9% average CAGR, $1.3M calculated opportunity.

## Diversification opportunities

- HS 300490: 2 buyer markets, $19.0B calculated opportunity.
- HS 382200: 2 buyer markets, $794.5M calculated opportunity.
- HS 300590: 2 buyer markets, $410.8M calculated opportunity.
- HS 300220: 2 buyer markets, $281.6M calculated opportunity.
- HS 350699: 2 buyer markets, $1.8M calculated opportunity.
- HS 370790: 1 buyer markets, $380.9M calculated opportunity.
- HS 330499: 1 buyer markets, $336.6M calculated opportunity.
- HS 380991: 1 buyer markets, $174.8M calculated opportunity.
- HS 300610: 1 buyer markets, $75.0M calculated opportunity.
- HS 330690: 1 buyer markets, $12.9M calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.